Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11910788
Mouse having a humanized cluster of differentiation 47 gene
granted -
US 11910787
Rodents having a humanized TMPRSS gene
granted -
US 11912767
EGFR × CD28 multispecific antibodies
granted -
US 11904017
Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab
granted -
US 11905332
Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof
granted -
US 11897945
Methods of treating allergy using anti-Bet v 1 antibodies
granted -
US 11896682
Radiolabeled MET binding proteins for immuno-PET imaging and methods of use thereof
granted -
US 11891607
Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
granted -
US 11884736
Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)
granted -
US 11884707
Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same
granted -
US 11866502
Anti-FGFR2 antibodies and methods of use thereof
granted -
US 11866503
Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor
granted -
US 11866794
Cas-ready mouse embryonic stem cells and mice and uses thereof
granted -
US 11865134
Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7) inhibitors
granted -
US 11850535
Methods for quantitating individual antibodies from a mixture
granted -
US 11844765
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11845963
HSD17B13 variants and uses thereof
granted -
US 11845800
Methods for treating or preventing asthma by administering an IL-4R antagonist
granted -
US 11845989
Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
granted -
US 11845931
CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation
granted -
US 11845957
Models of tauopathy
granted -
US 11834500
Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereof
granted -
US 11834485
IL-2 variants with reduced binding to IL-2 receptor alpha and uses thereof
granted -
US 11825819
Crnn loss of function rodent model
granted